Analystreport

Jazz Pharmaceuticals plc - (NASDAQ: JAZZ) was upgraded by analysts at Morgan Stanley to a "buy" rating.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com